We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.08%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$99B
AUM Growth
-$13.3B
(-12%)
Cap. Flow
-$12.9B
Cap. Flow
% of AUM
-13%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
4,867
New
290
Increased
1,487
Reduced
2,300
Closed
529
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$451M |
| 2 |
SPDR Gold Trust
GLD
|
+$392M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$363M |
| 4 |
Cisco
CSCO
|
+$328M |
| 5 |
Crown Castle
CCI
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$750M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$523M |
| 4 |
LVLT
Level 3 Communications Inc
LVLT
|
+$350M |
| 5 |
Apple
AAPL
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.92% |
| 2 | Financials | 10.74% |
| 3 | Technology | 10.54% |
| 4 | Energy | 7.9% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
iShares Morningstar Value ETF
ILCV
$1.35B
| $1.16M | ﹤0.01% |
27,796
+12,370
| +80% | +$523K |
|
2727
Monro
MNRO
$410M
| $1.16M | ﹤0.01% |
17,898
+6,617
| +59% | +$405K |
|
2728
Main Street Capital
MAIN
$5.31B
| $1.16M | ﹤0.01% |
37,640
-1,740
| -4% | -$52.4K |
|
2729
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $1.16M | ﹤0.01% |
21,781
-19,994
| -48% | -$1.06M |
|
2730
Supernus Pharmaceuticals
SUPN
$2.51B
| $1.16M | ﹤0.01% |
96,118
-65,037
| -40% | -$615K |
|
|
FHK
2731
DELISTED
First Trust Hong Kong AlphaDEX Fund
FHK
| $1.16M | ﹤0.01% |
27,043
+19,441
| +256% | +$785K |
|
2732
Invesco DB Commodity Index Tracking Fund
DBC
$1.63B
| $1.16M | ﹤0.01% |
67,779
+22,745
| +51% | +$400K |
|
|
ARNA
2733
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.16M | ﹤0.01% |
26,494
-31,251
| -54% | -$1.45M |
|
2734
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
| $1.15M | ﹤0.01% |
+23,037
| New | +$1.15M |
|
|
PETX
2735
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.15M | ﹤0.01% |
71,930
+16,579
| +30% | +$295K |
|
2736
B2Gold
BTG
$5.18B
| $1.15M | ﹤0.01% |
756,589
-253,452
| -25% | -$445K |
|
2737
1-800-Flowers.com
FLWS
$265M
| $1.15M | ﹤0.01% |
97,340
+46,786
| +93% | +$477K |
|
2738
B&G Foods
BGS
$289M
| $1.15M | ﹤0.01% |
39,025
-65,654
| -63% | -$1.93M |
|
|
IMGN
2739
DELISTED
Immunogen Inc
IMGN
| $1.15M | ﹤0.01% |
128,221
-57,948
| -31% | -$420K |
|
2740
iShares S&P Small-Cap 600 Value ETF
IJS
$8.41B
| $1.15M | ﹤0.01% |
19,274
+1,182
| +7% | +$68.7K |
|
|
ITCI
2741
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.14M | ﹤0.01% |
+47,794
| New | +$1.07M |
|
|
TTPH
2742
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $1.14M | ﹤0.01% |
1,555
+651
| +72% | +$489K |
|
2743
Smith & Nephew
SNN
$12.8B
| $1.14M | ﹤0.01% |
33,306
-4,093
| -11% | -$145K |
|
|
FTD
2744
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $1.14M | ﹤0.01% |
37,983
+3,053
| +9% | +$102K |
|
|
FPO
2745
DELISTED
First Potomac Realty Trust
FPO
| $1.14M | ﹤0.01% |
95,566
-7,454
| -7% | -$91.7K |
|
|
RJET
2746
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $1.13M | ﹤0.01% |
82,543
-51,156
| -38% | -$706K |
|
|
GHDX
2747
DELISTED
Genomic Health, Inc.
GHDX
| $1.13M | ﹤0.01% |
37,010
+9,354
| +34% | +$297K |
|
|
GIMO
2748
DELISTED
Gigamon Inc.
GIMO
| $1.13M | ﹤0.01% |
53,199
-6,211
| -10% | -$120K |
|
2749
Caleres
CAL
$479M
| $1.13M | ﹤0.01% |
34,404
-58,388
| -63% | -$1.78M |
|
|
SIGM
2750
DELISTED
Sigma Designs Inc
SIGM
| $1.13M | ﹤0.01% |
140,624
+69,097
| +97% | +$494K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2015 Portfolio in Review
As of Q1 2015, Credit Suisse held 4,867 positions worth $99B, down 12% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Credit Suisse withdrew a net $12.9B in Q1 2015, closing 529 positions and reducing 2,300 holdings. Its most notable exit was Allergan Inc, an estimated $280M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, Credit Suisse opened a new position in Medtronic worth $266M.
- Credit Suisse's largest Q1 2015 buy was Medtronic: 3,416,666 shares worth $266M.
- Credit Suisse added most to KRAFT FOODS GROUP INC COM STK (VA) in Q1 2015, an estimated $451M increase.
- Credit Suisse's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.16B.
- Credit Suisse fully exited Allergan Inc in Q1 2015, selling an estimated $280M.
- Credit Suisse's ten largest holdings make up 12% of its $99B portfolio in Q1 2015.
- Credit Suisse opened 290 new positions and closed 529 in Q1 2015.
- Credit Suisse's portfolio value fell 12% quarter-over-quarter to $99B.
Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.